FDA Approval: PROVOCHOLINE (METHACHOLINE CHLORIDE) — Type 1 - New Molecular Entity
Policy FDA-NDA019193 · Pulmonology
Provocholine (Methacholine Chloride) is an injectable drug likely to receive a specific J-code for billing. As a Part B candidate, it may be eligible for pass-through payment or reimbursed at ASP+6%.